ClinicalTrials.gg
RecruitingNCT07500103SINCROUpdated Mar 30, 2026

Spatiotemporal Entrainment Neuromodulation Targeting Cerebello-Cerebral Circuits to Enhance Cognitive and Social Rehabilitation in Cerebellar Diseases

An interventional study of EEg-guided High-Definition transcranial alternate current stimulation (HD-tACS) and Immersive Virtual Reality (IVR) Social Prediction training in Cerebellar Degeneration and Cerebellar Malformation, sponsored by I.R.C.C.S. Fondazione Santa Lucia. Recruiting at 2 sites in Italy. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by I.R.C.C.S. Fondazione Santa Lucia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jan 2025, registered Mar 2026).
  • Started Jan 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

The cerebellum is increasingly recognized for its crucial role in high-level cognitive processes, particularly in the domain of social cognition and action prediction. Disruptions in cerebellar circuits can lead to significant impairments in anticipating others' intentions and behaviors, affecting daily social interactions. This randomized, double-blind, sham-controlled trial protocol investigates the combined effects of personalized cerebellar High-Definition transcranial Alternating Current Stimulation (HD-tACS) and Immersive Virtual Reality (IVR) training on social prediction abilities. The study involves two clinical populations: adolescents and young adults with congenital cerebellar malformations (CM) and adults with acquired neurodegenerative cerebellar atrophy (CA). Participants undergo eight daily sessions of IVR training designed to enhance internal models of social events through interactive scenarios. Simultaneously, they receive either active or sham HD-tACS delivered at their Individual Gamma Frequency (IGF), determined via baseline EEG. The primary outcomes include behavioral responses to context-based social prediction tasks (action intentions, emotions, and personality traits). Secondary outcomes encompass electrophysiological measures, neuropsychological functioning, and adaptive behavior. By integrating neuromodulation with embodied virtual experiences, the project aims to facilitate cerebello-cerebral plasticity and provide a novel transdiagnostic rehabilitative approach for socio-cognitive impairments.

Read the detailed description

This represents the protocol of the RCT of the project "SINCRO: Spatiotemporal entrainment as Innovative Neuromodulation targeting Cerebello-cerebral circuits for enhancing Rehabilitation Outcomes of cognitive and social skills in progressive and acquired cerebellar diseases" (Italian Ministry of Health, RF-2021-12374279). The study employs two arms of a randomized, double-blind, sham-controlled, pre-post-test trial (RCT) with 30 adolescents and young adults with congenital cerebellar malformations (CM) and 30 adults with degenerative cerebellar atrophy (CA), respectively (see Eligibility Criteria section for details). Eligible patients are contacted by medical doctors and those willing to participate are enrolled. Participants undergo eight daily (1 hour) sessions of an IVR training of social prediction abilities (see Interventions section for details), receiving either active or sham cerebellar IGF HD-tACS (see Interventions section for details). Each participant is assigned randomly to either the active or sham group in a 1:1 allocation ratio, using a computer-generated blocked randomization process carried out by independent personnel not directly engaged in the study.

The intervention is carried out for 8 consecutive days for 1h/day. Patients with CM and CA are assessed before the start of treatment (T0), immediately after the end of treatment (T1) and two months after the end (T2). The overall RCT is structured as follows. In the first session prior to the beginning of the training (t0), the RCT includes the administration of all primary and secondary outcome measures (please refer to the outcome measures for a more detailed description). Among outcome measures, analyses of the cortical rhythms recorded by electroencephalogram (EEG) at rest are conducted to derive the Individualized Gamma Frequency (IGF), which is matched to each patient's specific stimulation frequency delivered through HD-tACS during the training. For each training day, the treatment lasts one hour. During the first 20 minutes of treatment the active or sham HD-tACS (according to the group allocation) is delivered. After the end of the stimulation, patients are asked to rate the sensations experienced during the stimulation through Visual Analogue Scales and through child-friendly Likert scales. Then, they perform the IVR social prediction training for the remaining session time without stimulation. Soon after the end of all the training sessions, patients carry out the T1 evaluation. As for the T0 session, this session includes the administration of all primary and secondary outcome measures. Two months after the end of the training (T2) all primary and secondary outcome measures, except for resting and task-related EEG recordings, are administered.

Primary outcomes will include the behavioural responses to three computer-assisted, context-based social prediction tasks and a non-social control task. Secondary outcomes include electrophysiological measures of anticipatory control, perception, and attention, cortical rhythms, neuropsychological tests, as well as scales for adaptive behavior, and fluid intelligence.

Staff conducting pre/post assessments, personnel leading the IVR training and researchers analyzing data are blinded, whereas the personnel administering the stimulation and the project administrators are not. The personnel administering the stimulation is the only person in the room aware of the correspondence between a specific code and stimulation protocol and leaves when the stimulation (either active or sham) is over, thus preventing any influence on training administration. Of note, the electrode placement procedure is identical for both sham and active stimulation conditions, which helps maintain blinding of both participants and study personnel to treatment allocation, ensuring that the personnel conducting the training remain unaware of the treatment allocation. Unblinding should only occur in rare cases where knowledge of the treatment is crucial for managing the patient, such as in the case of adverse events.

The intervention takes place at IRCCS Mondino Foundation (Pavia) for CM patients and at IRCCS Santa Lucia Foundation (Rome) for CA patients.

This trial is supported by the Italian Ministry of Health, project RF-2021-12374279 "SINCRO: Spatiotemporal entrainment as Innovative Neuromodulation targeting Cerebello-cerebral circuits for enhancing Rehabilitation Outcomes of cognitive and social skills in progressive and acquired cerebellar diseases"

02

Conditions studied

  • Cerebellar Degeneration
  • Cerebellar Malformation

Keywords

  • Cerebellum
  • Social prediction
  • tACS
  • Virtual Reality
03

In context

Lead sponsor

I.R.C.C.S. Fondazione Santa Lucia is the lead sponsor of 56 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for patients with cerebellar malformation include:

  • Documented malformations confined to the cerebellum confirmed by a 3T brain MRI scan;
  • Age ranging from 12 to 32 years old;
  • IQ >= 50;
  • Absence of extra-cerebellar malformations on conventional brain MRI scan.

Inclusion Criteria for patients with degenerative cerebellar atrophy include:

  • Evidence of diffuse cerebellar atrophy;
  • More than 6 months of illness;
  • IQ >=75;
  • Absence of any cortical lesion on conventional brain MRI scans

Exclusion Criteria for both groups include:

  • Presence of severe motor and visual impairments, as well as neurodevelopmental (i.e., autism), neurological or psychiatric disorders that could interfere with task execution and protocol compliance;
  • Presence of any for tACS.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Active HD-tACS combined with IVR training

    At the beginning of each training session, EEG-guided active HD-tACS at the IGF will be applied for the first 20 minutes. After the stimulation, participants will be asked to report the sensations and possible side effects occurring during tACS and to rate their feelings on several visual analogue scales and Likert scales. Following the stimulation, the IVR social prediction training will be administered.

    Device: EEg-guided High-Definition transcranial alternate current stimulation (HD-tACS) · Behavioral: Immersive Virtual Reality (IVR) Social Prediction training

  • Sham comparator
    Sham HD-tACS combined with VR training

    At the beginning of each training session, EEG-guided sham HD-tACS will be applied for the first 20 minutes. In this condition, after the initial 30 seconds of ramp-up phase of the current, the stimulation is switched off. This procedure allows participants to feel the characteristic tingling sensations in the vicinity of the electrodes for a brief period of time, which enhances the plausibility of blinding. After 20 minutes from setting-up the stimulation, participants will be asked to report the sensations and possible side effects occurring during tACS and to rate their feelings on several visual analogue scales and Likert scales. Following the stimulation, the IVR social prediction training will be administered.

    Device: EEg-guided High-Definition transcranial alternate current stimulation (HD-tACS) · Behavioral: Immersive Virtual Reality (IVR) Social Prediction training

Interventions

  • DeviceEEg-guided High-Definition transcranial alternate current stimulation (HD-tACS)

    EEG-guided HD-tACS is delivered via a CE-marked Starstim® 8-channel device using a multifocal montage with the active ring electrode centered over the left cerebellar hemisphere (2 cm below and 3 cm left of the inion) and four equidistant references (4 cm). This configuration, validated by SimNIBS 4.1 electric field modeling, targets cerebellar regions linked to mentalizing connectivity. Stimulation is applied for 20 minutes daily at 1 mA peak-to-peak intensity-selected for its safety and efficacy in younger participants-including 30-second ramp-up/down phases. In the sham condition, current is deactivated after the initial ramp-up to maintain blinding through transient tingling. The stimulation frequency is individually tailored to each participant's Individual Gamma Frequency (IGF), identified as the peak power within the 30-80 Hz band via Welch's PSD estimation of 19-channel EEG data (10/10 system) recorded at 500 Hz and processed using FIR filtering.

  • BehavioralImmersive Virtual Reality (IVR) Social Prediction training

    The protocol employs age-matched, immersive virtual scenarios developed in Blender and Unity, delivered via Meta Quest 2 HMD (120 Hz, 110° FOV) to ensure a high sense of presence. To maximize ecological validity through personalized settings, adolescents interact with school-based environments (library/playground), while adults use a supermarket or restaurant. From a first-person perspective with synchronous hand-tracking, participants observe three objects on a counter as an avatar approaches. Each session (40 mins) includes 88 trials where participants must infer and predict the avatar's preferred object category (e.g., beverages, books) and grasp it first. Three avatars follow specific preferences, while a fourth acts randomly; mappings are pseudo-randomized across eight sessions to ensure identity-based learning. Feedback is provided via auditory cues.

06

What researchers measure

Primary outcomes

  1. Context-based social prediction task

    Behavioral responses (accuracy and reaction times) to three ad-hoc computer-assisted social prediction tasks and one non-social control task. The three social prediction tasks measure the ability to use contextual information to infer and predict others' mental states or traits, including action intentions, emotional states, and personality traits. All tasks share a priming-target procedure where participants select between two interpretations of a target stimulus following a congruent or incongruent situational context. Specifically, the Action Intention task requires predicting if a hand-grasp is for using or moving an object; the Emotion task involves identifying happiness or fear in facial expressions; and the Personality Trait task assesses trustworthiness judgments based on moral or immoral behaviors. A Non-social Control task requiring the classification of natural or artificial objects in indoor/outdoor environments is used as a control.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

Secondary outcomes

  1. Cognitive discrimination response task (DRT)

    This computer-assisted task is used as an index of perceptual and cognitive control, such as inhibition, a core executive function supporting social cognition. Participants respond quickly to target stimuli and withhold responses to non-target stimuli.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1)

  2. High-density event-related potentials (ERPs) recording

    ERPs are measured during the DRT, to examine pre- and post-stimulus activity, capturing reactive sensory-motor processes, proactive motor preparation, and cognitive anticipation

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1)

  3. Cortical rhythms

    EEG recordings are collected at rest (5 minutes) and during the DRT (15 minutes) to assess changes in delta, alpha, beta, and gamma power across time points, focusing on regions linked to socio-cognitive functions

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1)

  4. NEPSY-II: Social Perception

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It assesses the ability to recognize facial affect and understand mental states (Theory of Mind).

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  5. NEPSY-II: Attention and Executive Functioning

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It evaluates selective attention, inhibitory control, and cognitive flexibility.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  6. NEPSY-II: Language

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It assesses phonological awareness, verbal retrieval, and receptive language.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  7. NEPSY-II: Memory and Learning

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It measures immediate and delayed recall for both verbal and visuospatial information.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  8. NEPSY-II: Sensorimotor functions

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It evaluates fine motor coordination, finger dexterity, and visuomotor precision.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  9. NEPSY-II: Visuospatial Processing

    For participants ≤16 years, a domain-specific Composite Score is calculated as the arithmetic mean of the age-standardized scaled scores (Mean=10, SD=3; range 1-19) of the administered subtests. It measures visual-perceptual analysis, orientation, and mental rotation.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  10. Reading the Mind in the Eyes Test (RMET)

    For participants \>16 years, an advanced test of Theory of Mind and social intelligence is administered. The outcome is the total number of correctly identified mental states from photographs of the eye region.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  11. Faux Pas Recognition Test

    For participants \>16 years, a measure of social cognition and the ability to detect social "faux pas" is administered. Outcomes include total scores for detecting, identifying, and explaining social transgressions.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  12. Albert Test

    For participants \>16 years, a screening task for visual attention is administered. The outcome is typically reported as the number of lines crossed or a omission score, assessing spatial attention and orientation.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  13. Stroop Test

    For participants \>16 years, a measure of selective attention and cognitive inhibition iss administered. Outcomes include completion time and error rates across three conditions (Word, Color, and Color-Word interference).

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  14. Token test

    For participants \>16 years, a measure of receptive language and oral command comprehension is administered. The outcome is the total number of correct responses (maximum score varies by version, e.g., 36 or 62).

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  15. Rey Auditory Verbal Learning Test (RAVLT)

    For participants \>16 years, an assessment of verbal learning and memory is administered. Outcomes include Immediate Recall (sum of trials 1-5), Delayed Recall (after 20-30 min), and Recognition scores.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  16. Rey-Osterrieth Complex Figure

    For participants \>16 years, a measure of visuospatial construction and visual memory is administered. Outcomes are accuracy scores (0-36 points).

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  17. WAIS-IV: Block Design

    For participants \>16 years, a subtest measuring visuospatial organization, non-verbal reasoning, and visual-motor integration is administered. The outcome is reported as an age-standardized scaled score (Mean=10, SD=3).

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  18. International Cooperative Ataxia Rating Scale (ICARS)

    For participants ≥ 18 years, a semi-quantitative clinical scale (0-100 points) is used to assess the severity of cerebellar ataxia. It evaluates four subdomains: posture and gait, limb coordination, speech disorders, and oculomotor disorders. Higher scores indicate greater impairment.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  19. Cerebellar Cognitive Affective Syndrome Scale (CCAS)

    For participants ≥ 18 years, a specialized screening tool is administered to detect cognitive and behavioral deficits associated with cerebellar lesions. It assesses executive function, linguistic processing, visuospatial abilities, and emotional regulation.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  20. Vineland Adaptive Behavior Scales, Second Edition (VABS-II)

    This tool is designed to assess adaptive behavior in individuals from birth to age 90 years, including open-ended questions to gather in-depth information. This scale is used to assess adaptive skills across 4 domains: communication, daily living skills, socialization and motor skills. It provides 5 scores for each domain and a total score on a 100 ± 15 distribution.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

  21. Coloured Progressive Matrices (CPM47)

    A non-verbal measure of reasoning and fluid intelligence, consisting of 47 items requiring identification of the missing element in visual patterns.

    Time frame: 1-2 days before the start of training (t0), 1-2 days after the end of the training (t1), two months after the end of the training (t2)

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized dataset will be available at https://zenodo.org/

Time frame: Before data analyses, for ten years.

Access criteria: Data are publicly accessible, but files will be restricted to users with access to the repository platform.

Data sharing details ↗ · zenodo.org

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Feb 2027, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2026
First posted
Mar 30, 2026
StartActual
Jan 15, 2025
Primary completionEst.
Feb 2027
CompletionEst.
Apr 2027
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07500103
Lead sponsor
I.R.C.C.S. Fondazione Santa Lucia
Collaborators
IRCCS National Neurological Institute "C. Mondino" Foundation
Responsible party
Sponsor
First posted
Mar 30, 2026
Start date
Jan 15, 2025
Primary completion
Feb 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Mar 30, 2026

Study contacts

Maria Leggio, MD, PhD
Contact
m.leggio@hsantalucia.it
+39 06 49917645
Renato Borgatti, MD, PhD
Contact
renato.borgatti@mondino.it
+39 0382 38021
Maria Leggio, MD, PhD
principal investigator · I.R.C.C.S. Fondazione Santa Lucia
Renato Borgatti, MD, PhD
principal investigator · IRCCS National Neurological Institute "C. Mondino" Foundation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion